STAT February 23, 2023
Paul J. Hastings

The silence from corporate America amid new attacks on women’s reproductive health care has been deafening. As the federal courts consider whether to override the FDA’s judgment on first-trimester abortion pills, it’s time for health care leaders to speak out about the repercussions of taking away medical sovereignty from 40 million women.

January 2023 marked 50 years since Roe vs. Wade gave Americans the freedom to make difficult, deeply personal medical decisions about their pregnancies based on their unique life circumstances, including potential risks to maternal health.

It took the newly constituted U.S. Supreme Court less than two years to eviscerate that right as it fast-tracked Roe’s reversal with insufficient regard for how their ruling would impact maternal health and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: FDA, Govt Agencies, Patient / Consumer, Provider
Your Friends Might Be Influencing Your Gut Microbiome: Study
AI Teaches Surgery; AI Quality Registry; AI Matches Patients With Trials
Social epidemics and the role of physicians
The risk of a bird flu pandemic is rising
The growing impact of behavioral health platforms in meeting mental health care needs

Share This Article